Abcam Company
Abcam helps researches with breakthroughs in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders.
Founded Date:
1998
Last Funding Type:
Series B
Headquarters:
Cambridge, United Kingdom
Investors Number:
6
Technology:
Research Kit or Other Laboratory Practice Supplies
Industry:
Omics-based, Systemic
Estimated Revenue:
$50M to $100M
Number Of Exists:
1001-5000
Total Funding:
$37.7M